BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34979570)

  • 1. Post-endoscopy Barrett's neoplasia after a negative index endoscopy: a systematic review and proposal for definitions and performance measures in endoscopy.
    Desai M; Lieberman D; Srinivasan S; Nutalapati V; Challa A; Kalgotra P; Sundaram S; Repici A; Hassan C; Kaminski MF; Sharma P
    Endoscopy; 2022 Sep; 54(9):881-889. PubMed ID: 34979570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating neoplasia detection rate (NDR) in patients with Barrett's oesophagus based on index endoscopy: a systematic review and meta-analysis.
    Parasa S; Desai M; Vittal A; Chandrasekar VT; Pervez A; Kennedy KF; Gupta N; Shaheen NJ; Sharma P
    Gut; 2019 Dec; 68(12):2122-2128. PubMed ID: 30872393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review with meta-analysis: neoplasia detection rate and post-endoscopy Barrett's neoplasia in Barrett's oesophagus.
    Hamade N; Kamboj AK; Krishnamoorthi R; Singh S; Hassett LC; Katzka DA; Kahi CJ; Fatima H; Iyer PG
    Aliment Pharmacol Ther; 2021 Sep; 54(5):546-559. PubMed ID: 34275161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study.
    Visrodia K; Iyer PG; Schleck CD; Zinsmeister AR; Katzka DA
    Dig Dis Sci; 2016 Jan; 61(1):158-67. PubMed ID: 25956705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
    Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
    Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk for esophageal neoplasia in Barrett's esophagus patients with mucosal changes indefinite for dysplasia.
    Horvath B; Singh P; Xie H; Thota PN; Allende DS; Pai RK; Patil DT; Plesec TP; Goldblum JR; Liu X
    J Gastroenterol Hepatol; 2015 Feb; 30(2):262-7. PubMed ID: 25087917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium.
    Desai M; Lieberman DA; Kennedy KF; Hamade N; Thota P; Parasa S; Gorrepati VS; Bansal A; Gupta N; Gaddam S; Young PE; Mathur S; Moawad FJ; Cash BD; Sampliner R; Vargo JJ; Falk GW; Sharma P
    Gastrointest Endosc; 2019 Feb; 89(2):257-263.e3. PubMed ID: 30342028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review with meta-analysis: prevalent vs. incident oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus.
    Visrodia K; Singh S; Krishnamoorthi R; Ahlquist DA; Wang KK; Iyer PG; Katzka DA
    Aliment Pharmacol Ther; 2016 Oct; 44(8):775-84. PubMed ID: 27562355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
    Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoplasia Detection Rate in Barrett's Esophagus and Its Impact on Missed Dysplasia: Results from a Large Population-Based Database.
    Dhaliwal L; Codipilly DC; Gandhi P; Johnson ML; Lansing R; Wang KK; Leggett CL; Katzka DA; Iyer PG
    Clin Gastroenterol Hepatol; 2021 May; 19(5):922-929.e1. PubMed ID: 32707339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy.
    Borovicka J; Fischer J; Neuweiler J; Netzer P; Gschossmann J; Ehmann T; Bauerfeind P; Dorta G; Zürcher U; Binek J; Meyenberger C
    Endoscopy; 2006 Sep; 38(9):867-72. PubMed ID: 16981102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of young patients with early Barrett's neoplasia.
    Iwaya Y; Shimamura Y; Goda K; Rodríguez de Santiago E; Coneys JG; Mosko JD; Kandel G; Kortan P; May G; Marcon N; Teshima C
    World J Gastroenterol; 2019 Jun; 25(24):3069-3078. PubMed ID: 31293342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis.
    Yousef F; Cardwell C; Cantwell MM; Galway K; Johnston BT; Murray L
    Am J Epidemiol; 2008 Aug; 168(3):237-49. PubMed ID: 18550563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.
    Wani S; Falk G; Hall M; Gaddam S; Wang A; Gupta N; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Reddymasu S; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Lieberman DA; Sampliner RE; Sharma P
    Clin Gastroenterol Hepatol; 2011 Mar; 9(3):220-7; quiz e26. PubMed ID: 21115133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance in Barrett's esophagus: an audit of practice.
    Ajumobi A; Bahjri K; Jackson C; Griffin R
    Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?
    Kunzmann AT; Coleman HG; Johnston BT; Turkington RC; McManus D; Anderson LA; Thrift AP
    Dig Dis Sci; 2021 Jun; 66(6):1965-1973. PubMed ID: 32734400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus.
    Waterhouse DJ; Januszewicz W; Ali S; Fitzgerald RC; di Pietro M; Bohndiek SE
    Cancer Res; 2021 Jun; 81(12):3415-3425. PubMed ID: 34039635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of adenocarcinoma among patients with Barrett's esophagus.
    Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P
    N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.
    Thota PN; Lee HJ; Goldblum JR; Liu X; Sanaka MR; Gohel T; Kanadiya M; Lopez R
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):459-465.e1. PubMed ID: 25102445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.